688085 三友医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.8460.5995.09010.82511.575
总资产报酬率 ROA (%)1.5840.5024.2939.11110.162
投入资产回报率 ROIC (%)1.7910.5865.00310.61211.430

边际利润分析
销售毛利率 (%)72.76671.33579.95190.17790.500
营业利润率 (%)14.8714.64426.15735.29134.384
息税前利润/营业总收入 (%)14.6282.88825.80135.50535.372
净利润/营业总收入 (%)12.7602.67024.68331.35732.889

收益指标分析
经营活动净收益/利润总额(%)94.244140.30388.58480.46572.818
价值变动净收益/利润总额(%)-1.07125.939-4.37419.51924.739
营业外收支净额/利润总额(%)8.1193.82310.7094.3616.125

偿债能力分析
流动比率 (X)5.3174.5974.8674.0584.898
速动比率 (X)3.9703.5033.9583.4254.381
资产负债率 (%)10.19211.1819.67512.70213.063
带息债务/全部投入资本 (%)1.5911.9250.1140.2650.376
股东权益/带息债务 (%)6,110.4835,030.11886,824.46337,006.60526,117.978
股东权益/负债合计 (%)870.808741.261875.789660.947646.174
利息保障倍数 (X)-9.395-1.487-7.385-25.431-28.177

营运能力分析
应收账款周转天数 (天)57.35153.439131.716145.361135.070
存货周转天数 (天)690.601585.276646.942780.653685.469